ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 243 filers reported holding ICU MED INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $722,238 | +19.3% | 6,082 | +7.9% | 0.01% | +25.0% |
Q1 2024 | $605,177 | +5.8% | 5,639 | -1.7% | 0.00% | 0.0% |
Q4 2023 | $572,009 | -17.5% | 5,735 | -1.5% | 0.00% | -33.3% |
Q3 2023 | $693,114 | -32.3% | 5,824 | +1.4% | 0.01% | -25.0% |
Q2 2023 | $1,023,702 | +5.1% | 5,745 | -2.7% | 0.01% | -11.1% |
Q1 2023 | $974,254 | +7.9% | 5,906 | +3.0% | 0.01% | 0.0% |
Q4 2022 | $902,675 | +8.6% | 5,732 | +3.8% | 0.01% | 0.0% |
Q3 2022 | $831,000 | -7.8% | 5,520 | +0.7% | 0.01% | 0.0% |
Q2 2022 | $901,000 | -25.8% | 5,479 | +0.5% | 0.01% | -10.0% |
Q1 2022 | $1,214,000 | -5.7% | 5,454 | +0.6% | 0.01% | 0.0% |
Q4 2021 | $1,287,000 | +0.5% | 5,423 | -1.2% | 0.01% | 0.0% |
Q3 2021 | $1,281,000 | +14.5% | 5,491 | +1.0% | 0.01% | +11.1% |
Q2 2021 | $1,119,000 | -6.1% | 5,438 | -6.3% | 0.01% | -10.0% |
Q1 2021 | $1,192,000 | -3.6% | 5,802 | +0.6% | 0.01% | -9.1% |
Q4 2020 | $1,237,000 | +13.4% | 5,768 | -3.4% | 0.01% | 0.0% |
Q3 2020 | $1,091,000 | +33.5% | 5,971 | +34.7% | 0.01% | -8.3% |
Q2 2020 | $817,000 | -12.2% | 4,433 | -3.9% | 0.01% | -25.0% |
Q1 2020 | $930,000 | -54.4% | 4,611 | -57.7% | 0.02% | -36.0% |
Q4 2019 | $2,040,000 | +6.7% | 10,902 | -9.0% | 0.02% | +8.7% |
Q3 2019 | $1,912,000 | -37.4% | 11,978 | -1.2% | 0.02% | -34.3% |
Q2 2019 | $3,053,000 | +7.0% | 12,119 | +1.6% | 0.04% | +2.9% |
Q1 2019 | $2,854,000 | +4.4% | 11,923 | +0.1% | 0.03% | -2.9% |
Q4 2018 | $2,735,000 | -17.8% | 11,912 | +1.2% | 0.04% | +12.9% |
Q3 2018 | $3,329,000 | +7.1% | 11,772 | +11.3% | 0.03% | 0.0% |
Q2 2018 | $3,107,000 | +20.7% | 10,579 | +3.7% | 0.03% | +19.2% |
Q1 2018 | $2,574,000 | -53.0% | 10,200 | -59.8% | 0.03% | -50.9% |
Q4 2017 | $5,481,000 | +279.3% | 25,377 | +226.4% | 0.05% | +211.8% |
Q3 2017 | $1,445,000 | +6.4% | 7,774 | -1.3% | 0.02% | -10.5% |
Q2 2017 | $1,358,000 | +14.4% | 7,874 | +1.3% | 0.02% | +11.8% |
Q1 2017 | $1,187,000 | +6.5% | 7,774 | +2.8% | 0.02% | +6.2% |
Q4 2016 | $1,115,000 | +18.2% | 7,564 | +1.3% | 0.02% | +14.3% |
Q3 2016 | $943,000 | +10.6% | 7,464 | -1.3% | 0.01% | +16.7% |
Q2 2016 | $853,000 | +11.2% | 7,564 | +2.7% | 0.01% | +20.0% |
Q1 2016 | $767,000 | -5.1% | 7,364 | +2.8% | 0.01% | -9.1% |
Q4 2015 | $808,000 | +9.0% | 7,164 | +5.9% | 0.01% | +10.0% |
Q3 2015 | $741,000 | -4.1% | 6,764 | -28.4% | 0.01% | +11.1% |
Q4 2014 | $773,000 | +28.8% | 9,450 | +1.1% | 0.01% | +28.6% |
Q3 2014 | $600,000 | +0.3% | 9,350 | -5.1% | 0.01% | 0.0% |
Q2 2014 | $598,000 | +3.6% | 9,850 | +2.1% | 0.01% | 0.0% |
Q1 2014 | $577,000 | -13.2% | 9,650 | -7.7% | 0.01% | -12.5% |
Q4 2013 | $665,000 | -16.7% | 10,450 | -11.1% | 0.01% | -20.0% |
Q3 2013 | $798,000 | -4.1% | 11,750 | +1.7% | 0.01% | -9.1% |
Q2 2013 | $832,000 | +25.5% | 11,550 | +2.7% | 0.01% | +22.2% |
Q1 2013 | $663,000 | – | 11,250 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
GAM Holding AG | 90,452 | $20,769,000 | 1.05% |